Member Info for AquaeSulis01

Mad, no-one is sweating on the results, it is more about SA delivering on the timetables he sets himself. No-one coerced him into providing a date for the Results, he volunteered it during an interview. This follows his other recent "misspeak" regarding the date the Oral Study was due to conclude which moved from 2024 to Summer 2023 before reverting back to 2024; i.e. more about credibility that sweating.

Life in the display market still with QD-OLED seen as a key differentiator in the premium TV Market, so if others wish to compete....

"QD-OLED, a self-emissive display with quantum dots (semiconductor particles a few nanometers in size)

in the panel to maximize color gamut and viewing angle, is capturing attention under expectations that it will lead the

premium TV and monitor markets."

"In the large panel business, we will continue to increase our market share in the premium market by expanding the line up of QD-OLED products and diversifying distributors."

https://www.rns-pdf.londonstockexchange.com/rns/2035V_1-2023-11-30.pdf

"

Well, I suppose we have until cop today for the Results RNS to be released but if it fails to arrive then elrico you might need to inform the BBC that you have revived Jackanory for Adults in the guise of your interviews with Stuart :)

"Jackanory is a BBC children's television series which was originally broadcast between 1965 and 1996. It was designed to stimulate an interest in reading.[1] The show was first transmitted on 13 December 1965, and the first story was the fairy-tale "Cap-o'-Rushes" read by Lee Montague. Jackanory continued to be broadcast until 1996, with around 3,500 episodes in its 30-year run. The final story, The House at Pooh Corner by A. A. Milne, was read by Alan Bennett and broadcast on 24 March 1996. The show was briefly revived on 27 November 2006 for two one-off stories, and the format was revived as Jackanory Junior on CBeebies between 2007 and 2009."

Https://www.costco.com.au/Health-Beauty/Vitamins-Diet-Nutrition/Dietary-Supplements/Optislim-Premium-Shake-For-Her-168kg-Chocolate/p/176809-CLT

Good job the signup is with Ravenswood in NZ then with Costco launch in Australia

Last year was late because they did not have the placing done soon enough, this year's will be on time in Nov

Wonder if we will get some news regarding the Acne launch in the results RNS due out by Thursday; has recruitment started, has it launched or has it been deferred until Jan 2024?

Irrespective of the launch date, the incorporation of a successful blend into chewing gum is very much achievable

https://www.linkedin.com/posts/bjp-laboratories-pty-ltd_httpswwwbjplaboratoriescomau-activity-7133277881161445377-iaCk?trk=public_profile_like_view

Thanks for posting mol but as others have pointed out the company appears similar in nature to wallstreet in terms of its superficial analysis. For example "ProBiotix was spun off from Optibiotix in March 2022, and the numbers to its year end in June 2022 were for the three months after the flotation: these amounted to revenues of £306,000 and an operating loss of £256,000, and cash at that time of £2,034,000. It is a finished product company as opposed to Opti which sells ingredients. " try telling that to Seed Health who are Pbx's biggest revenue generator by far and take LPLDL as an ingredient to be incorporated in their DS01 product

That's very ageist Niknak, I know some very active 80 yo's who are very grateful to have a healthy pension pot to draw on.

Look, we are talking 2024 for an anticipated further sp uplift supported by revenue growth on 1st gen products and the launch of second gen products, and as for LTH's, many will have averaged down when the sp sank to circa 6p whilst a number of new investors added at various points on the share price rise all on the back of a Reach RNS that brought nothing new that current investors didn't already know about but demonstrated the potential value of the company to a new investor audience.

Cheers elrico, 2023 will show a steady but unspectacular revenue recovery but H1 2024 is looking spectacular for revenue generation and should be topped by news on a sweetbiotix soft launch. It may not be enough to satisfy the short term traders like the midget off the Man with the Golden Gun movie, but will see a steady sp climb for the LTHs.. searching on Costco and optibiome will show the Costco launching Australia

Not ours but shows the market is there for a fibre based sweetener that does not have any unpleasant after taste.

"As for the fiber-dense cola, its flavor reminds me of cola gummies, but sugar free and with a noticeable artificial sweetener aftertaste, thanks to the aspartame, sucralose, and acesulfame potassium. It’s better tasting than a bowl of bran, but slightly less satisfying to my taste buds than a Diet Coke or Diet Pepsi.

I’ve purchased this Kirin Mets Tokuho Cola three times so far ($2.50) from a grocery store chain here that imports products from Japan, and it would’ve been more, if not for the fact that it sold out a couple of times. I guess I keep wanting to buy it because it tickles me that it has almost an entire day’s worth of fiber. As for gastrointestinal problems for drinking something with so much fiber, it wasn’t an issue because I didn’t chug the whole thing in one sitting. (Nope, not going to try it. Don’t ask.)

Would I buy a diet cola from Pepsi or Coke that has 89% of my daily fiber? If it tasted like Diet Coke or Diet Pepsi, I would. Would you, if you’re a diet cola drinker?"

https://www.theimpulsivebuy.com/wordpress/2023/08/14/kirin-mets-tokuho-cola-review/

Mad, you are confusing m/c with value, but feel free to list SA's actual achievements to date for comparison

Also worth pointing out that as the skin sp doubled from the previous Opti sale time that they did jump up significantly in SOH's eyes

Toyin, the para reads as follows "I cannot give you an absolute guarantee as if the SBTX shares jumped up to significantly I may want to cash in. Of course, then the sum of the parts would be based on a significantly higher market capitalisation for SBTX which is why I am still holding onto a significant chunk of SBTX shares. However, the rational conclusion from what I have said is that since we now have sufficient funds throughout 2024 we will not need to sell anymore SBTX shares in 2023. Hope that helps." So the words read "wont need" not "wont be selling" which tells me that the opportunity to accelerate marketing spend without crashing the Skin sp presented by new ii interest was taken.

As a Skin holder am I concerned? Not at all, as an Opti holder I am less pleased that the family silver is being sold off when O' Hara also recently speculated to Elric that he anticipates the Skin sp reaching £1 in the not too distant future.

Toyin, I suggest you re-listen to the TW Bearcast on 31st July, it was TW who summarised that SOH would not need to sell any more skin shares not SOH. The statement from TW was as follows "..all Business Units on track to be profitable by EOY and Company should at the PLC level hit profitability 2024, the odds are Opti wont have to raise any money this year so the BB Morons are wrong"; humble pie for Tom this morning because the BB Morons were right.

Now then regarding the sell it tells me one of two things, either the Business Units are not all heading for profitability by the EOY and more money is needed to fund marketing, and / or Unicorn made their request to buy into Skin known, and as we were told that the fund raise was over subscribed, there were insufficient shares on offer to meet Unicorn's requirement so a deal was made to acquire direct from Opti.

No it is not direcon. The x is against acquisition/disposal and the NUMBER of shares held (as opposed to just the percentage) has reduced

Worth remembering the other study underway with wellbiome that should be reporting in the near future

"I will be testing the effects of WellBiome on cardiac surgical outcomes following a pre-operative 6-week nutritional intervention. This project will be starting in Q3 of 2023."

https://www.hull.ac.uk/staff-directory/james-hobkirk

Toyin I know he was and at no point have I said I agree with not raising at this point in time have I, in fact I have stated in early posts what a good raise it was at 19p in the current market conditions? In other words I get the need to negotiate without a going concern on the books

Toying, when I made my original comment it was never intended as a opti v sbtx debate, just been taken out of context by Mad. As you state, and I made a similar caveat, TW spoilt his valid points by his aggressive manner. As for the £70k making a difference, that is more than the budget set aside for marketing and every little helps

How about handsomely rewarding a CEO when he delivers on his promises and we all share the rewards rather than before?